🇺🇸 FDA
Patent

US 12049642

Corneal endothelial cells with increased cell density and compositions thereof

granted A61KA61K35/30A61K45/06

Quick answer

US patent 12049642 (Corneal endothelial cells with increased cell density and compositions thereof) held by Astellas Institute for Regenerative Medicine expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Astellas Institute for Regenerative Medicine
Grant date
Tue Jul 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K35/30, A61K45/06, A61K9/0048